在慢性骨髓性白血病中,下一代印抑制剂的进展
Alessandro Costa1, Massimo Breccia2
1Hematology Unit, Businco Hospital, Department of Medical Sciences and Public Health, University of Cagliari Cagliari, Italy.
下一代特别准ABL1 Myristoyl口袋抑制剂 (STAMPi) 显示出对抗耐药慢性髓性白血病 (CML) 的承诺. 这些新型药物,包括TGRX-678,为晚期CML提供新的治疗途径和潜在的中枢神经系统透.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 专门针对ABL1的Myristoyl口袋抑制剂 (STAMPi) 已经彻底改变了慢性髓性白血病 (CML) 治疗.
- 挑战仍然存在,包括耐药性,突变,不耐受性和毒性,需要新的治疗策略.
研究的目的:
- 审查下一代STAMPi的临床前和早期临床数据.
- 评估新型STAMPi药物在克服耐药性和改善CML管理方面的潜力.
主要方法:
- 关于新型STAMPi的临床前发现和早期临床试验结果的摘要.
- 对野生型和突变ABL1的药物活性分析,包括T315I.
- 评估与其他氨酸激酶抑制剂 (TKI) 和中枢神经系统 (CNS) 透的协同作用潜力.
主要成果:
- TGRX-678对ABL1突变表现出强烈的活性,与TKIs协同作用,透到中枢神经系统,并且在严重预先治疗的CML患者中显示出令人鼓舞的临床活性.
- TERN-701还显示了来自CARDINAL试验的有希望的早期数据.
结论:
- 下一代STAMPi为CML提供了扩展的治疗选择,解决了耐药性,并使双部位抑制成为可能.
- TGRX-678的中枢神经系统透可能有利于爆发期CML和费城染色体阳性急性淋巴细胞白血病的患者.
- 需要进一步的试验来确定长期的安全性,耐用性和最佳的整合,以治愈导向策略的现有疗法.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
相关概念视频
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Extraction: Advanced Methods
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Differentiation of Common Myeloid Progenitor Cells
Dipeptidyl Peptidase 4 Inhibitors
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
